Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis | Zendy

Juan AguilarCompany | Zendy; Ibai LosArcos | Zendy; Carles Pigrau | Zendy; Dolors Rodríguez-Pardo | Zendy; Nieves Larrosa | Zendy; Virginia Rodríguez | Zendy; Denisse Joan Sihuay-Diburga | Zendy; Benito Almirante | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis

Author(s) -

Juan AguilarCompany,

Ibai LosArcos,

Carles Pigrau,

Dolors Rodríguez-Pardo,

Nieves Larrosa,

Virginia Rodríguez,

Denisse Joan Sihuay-Diburga,

Benito Almirante

Publication year - 2016

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00447-16

Subject(s) - enteritis , fosfomycin , hypogammaglobulinemia , microbiology and biotechnology , campylobacter coli , antibiotics , campylobacter , medicine , biology , immunology , bacteria , genetics , antibody

We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research